Literature DB >> 20617356

An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.

Toshimichi Matsui1, Takashi Ishida, Toshihiro Tono, Takuhiro Yoshida, Shun-ichi Sato, Shunsei Hirohata.   

Abstract

A 29-year-old man and a 36-year-old man developed attacks of acute neuro-Behçet's disease (NB) (right Horner's syndrome and right hemiplegia and dysarthria, respectively) during the course of chronic progressive NB (acute on chronic). Although both patients recovered from acute NB after treatment with infliximab or corticosteroids, they continued to show manifestations of chronic progressive NB. It is suggested that acute NB and chronic progressive NB are different in their pathogenesis.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20617356     DOI： 10.1007/s10165-010-0332-4

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN： 1439-7595            Impact factor:   3.023


  6 in total

Review 1.  Infliximab for patients with neuro-Behcet's disease: case series and literature review.

Authors:  Afshin Borhani Haghighi; Anahid Safari; Mohammad Ali Nazarinia; Zahra Habibagahi; Saeedeh Shenavandeh
Journal:  Clin Rheumatol       Date:  2011-03-24       Impact factor: 2.980

2.  Ptosis and Mass Like Lesions in Behçet's Disease: A Rare Presentation.

Authors:  Seher Kir; Lütfi Akyol; Metin Özgen; Hediye Pinar Günbey; Mehmet Sayarlioğlu
Journal:  Arch Rheumatol       Date:  2017-10-16       Impact factor: 1.472

3.  Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.

Authors:  Ryo Kuroda; Junko Suzuki; Mizuho Muramatsu; Asami Tasaki; Mariko Yano; Noboru Imai; Masahiro Serizawa; Masahiro Kobari
Journal:  J Neurol       Date:  2013-11-01       Impact factor: 4.849

4.  Severe panuveitis in neuro-Behçet's disease in Malaysia: a case series.

Authors:  Khairuddin Othman; Ahmad Tajudin Liza-Sharmini; Mohtar Ibrahim; John Tharakan; Ryoji Yanai; Embong Zunaina
Journal:  Int Med Case Rep J       Date:  2017-02-07

5.  Infliximab is a plausible alternative for neurologic complications of Behçet disease.

Authors:  Burcu Zeydan; Ugur Uygunoglu; Sabahattin Saip; Onat N Demirci; Emire Seyahi; Serdal Ugurlu; Vedat Hamuryudan; Aksel Siva; Orhun H Kantarci
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-07-08

6.  Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis.

Authors:  Mizuho Ishido; Nobuyuki Horita; Masaki Takeuchi; Etsuko Shibuya; Takahiro Yamane; Tatsukata Kawagoe; Takehito Ishido; Kaoru Minegishi; Ryusuke Yoshimi; Yohei Kirino; Shunsei Hirohata; Yoshiaki Ishigatsubo; Mitsuhiro Takeno; Takeshi Kaneko; Nobuhisa Mizuki
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.